BCL2 and cancer: The comparative interaction analysis denoted that PSP binds to most of the amino acids with which the Venetoclax inhibitor interacts, suggesting PSP’s potential to act as an inhibitor of the Bcl-2 protein, thereby promoting apoptosis and the death of cancer cells.